tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GB:0MH6 Stock Latest News

Ipsen’s New Study on Odevixibat: Long-term Insights for PFIC Treatment
Company AnnouncementsIpsen’s New Study on Odevixibat: Long-term Insights for PFIC Treatment
8d ago
0MH6
Ipsen’s Odevixibat Study: A Potential Game-Changer for Alagille Syndrome
PremiumCompany Announcements
Ipsen’s Odevixibat Study: A Potential Game-Changer for Alagille Syndrome
23d ago
0MH6
Ipsen’s Real-World Study on Cabozantinib and Nivolumab: A Potential Game-Changer for RCC Treatment
PremiumCompany Announcements
Ipsen’s Real-World Study on Cabozantinib and Nivolumab: A Potential Game-Changer for RCC Treatment
1M ago
0MH6
Ipsen’s Innovative Approach to PBC: A Study on Itch and Sleep Patterns
PremiumCompany Announcements
Ipsen’s Innovative Approach to PBC: A Study on Itch and Sleep Patterns
1M ago
0MH6
Ipsen’s New Study on Palovarotene: Implications for Liver-Impaired Patients
PremiumCompany Announcements
Ipsen’s New Study on Palovarotene: Implications for Liver-Impaired Patients
1M ago
0MH6
Ipsen’s Odevixibat Study: A Closer Look at Pregnancy and Lactation Safety
PremiumCompany AnnouncementsIpsen’s Odevixibat Study: A Closer Look at Pregnancy and Lactation Safety
1M ago
0MH6
Ipsen’s Latest Clinical Study on IPN01194: A Potential Game-Changer in Oncology
Premium
Company Announcements
Ipsen’s Latest Clinical Study on IPN01194: A Potential Game-Changer in Oncology
1M ago
0MH6
Ipsen’s Phase II Osteosarcoma Study: A Potential Game Changer?
Premium
Company Announcements
Ipsen’s Phase II Osteosarcoma Study: A Potential Game Changer?
1M ago
0MH6
Ipsen’s Real-World Study on Elafibranor for PBC: A Potential Game-Changer?
PremiumCompany Announcements
Ipsen’s Real-World Study on Elafibranor for PBC: A Potential Game-Changer?
1M ago
0MH6
Ipsen’s Elafibranor Study: A Potential Breakthrough for PBC Treatment
PremiumCompany Announcements
Ipsen’s Elafibranor Study: A Potential Breakthrough for PBC Treatment
1M ago
0MH6
Ipsen’s Promising Phase II Migraine Study: A Potential Game Changer
PremiumCompany Announcements
Ipsen’s Promising Phase II Migraine Study: A Potential Game Changer
1M ago
0MH6
Ipsen’s Latest Study on Abobotulinumtoxin A: Implications for Investors
PremiumCompany Announcements
Ipsen’s Latest Study on Abobotulinumtoxin A: Implications for Investors
1M ago
0MH6
Ipsen’s Promising Study on IPN10200 for Cervical Dystonia: A Potential Game-Changer?
PremiumCompany AnnouncementsIpsen’s Promising Study on IPN10200 for Cervical Dystonia: A Potential Game-Changer?
1M ago
0MH6
Ipsen’s New Drug Study: A Potential Game-Changer for Advanced Solid Tumors
Premium
Company Announcements
Ipsen’s New Drug Study: A Potential Game-Changer for Advanced Solid Tumors
1M ago
0MH6
Ipsen’s Increlex® Study: Long-term Safety and Effectiveness in Focus
Premium
Company Announcements
Ipsen’s Increlex® Study: Long-term Safety and Effectiveness in Focus
1M ago
0MH6
Ipsen’s Phase III Study on Elafibranor: A Potential Game-Changer for Liver Disease Treatment
PremiumCompany Announcements
Ipsen’s Phase III Study on Elafibranor: A Potential Game-Changer for Liver Disease Treatment
1M ago
0MH6
Ipsen’s Dysport® Study: A Potential Game-Changer for Chronic Migraine Prevention
PremiumCompany Announcements
Ipsen’s Dysport® Study: A Potential Game-Changer for Chronic Migraine Prevention
1M ago
0MH6
Ipsen’s Study on Post-Stroke Spasticity: A Potential Game Changer for Patient Care
PremiumCompany Announcements
Ipsen’s Study on Post-Stroke Spasticity: A Potential Game Changer for Patient Care
1M ago
0MH6
Ipsen’s IPN10200 Study: A Potential Game-Changer in Spasticity Treatment
PremiumCompany Announcements
Ipsen’s IPN10200 Study: A Potential Game-Changer in Spasticity Treatment
1M ago
0MH6
Ipsen’s Dysport® Trial: A New Hope for Migraine Prevention?
PremiumCompany AnnouncementsIpsen’s Dysport® Trial: A New Hope for Migraine Prevention?
1M ago
0MH6
Ipsen’s New Study on IPN10200: A Potential Game-Changer for Cervical Dystonia Treatment
Premium
Company Announcements
Ipsen’s New Study on IPN10200: A Potential Game-Changer for Cervical Dystonia Treatment
2M ago
Ipsen’s Real-World Study on Renal Cell Carcinoma Treatment: Key Update
Premium
Company Announcements
Ipsen’s Real-World Study on Renal Cell Carcinoma Treatment: Key Update
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >